Actualizaciones en la gestión de farmacias

Humana strives to make the prescription process as simple as possible for providers and members. Some prescriptions, however, require more attention than others.

The Humana Clinical Pharmacy Review (HCPR) team oversees step therapy and handles requests related to prior authorization and overriding dispensing limits. The team is centrally located in Louisville, Ky., and operates Monday-Friday, 8 a.m. to 9 p.m. EST.

Autorizaciones previas
Algunos medicamentos deben atravesar un proceso de aprobación basado en criterios, previo a una decisión de cobertura. If you need to obtain prior authorization for a prescription, you can use one of the following methods:

1) Submit your request online with the new Web tool. (See the box on this page for more information.)

2) Call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m. to 9 p.m. EST. When calling in a request, be prepared with the following information:

  • Información demográfica del paciente
  • El medicamento solicitado
  • El diagnóstico del paciente
  • Any drug allergies or medical conditions
  • Otros tratamientos o procedimientos probados
  • Duración deseada del tratamiento

Most requests for authorization require appropriate lab information before they can be processed.

3) Fax the form to HCPR at (877) 486-2621. Fax forms can be downloaded online through the following process:

  • Go to the "Provider" area of www.humana.com
  • Under "Quick Links," choose "Prescription Tools"
  • Scroll down to the "Prior Authorization" link

You can also view a list of drugs that require prior authorization by clicking on "Humana's Drug List" on the same page as the "Prior Authorization" link.

Límites máximos de venta
Maximum dispensing limits are based on product information approved by the Federal Drug Administration (FDA) and recommendations from the drug's manufacturer. These limits are reviewed and approved by Humana's Pharmacy and Therapeutics Committee, which is composed of both pharmacists and physicians.

If a patient's medical condition warrants additional quantities, call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m.-9 p.m. EST. You should be prepared with the same information as for a prior authorization request (see list at left). For a list of drugs with a dispensing limit, take the following steps:

  • Go to the "Provider" area of www.humana.com
  • Under "Quick Links," choose "Prescription Tools"
  • Choose "Humana's Drug List"
  • Click on the link under "Quantity Limit" under "Updates"

Terapia escalonada
The Medicare Prescription Drug Plan is subject to step therapy protocols. Step therapy protocols require patients to utilize medications commonly considered first-line before using medications considered second-line or third-line. Estos protocolos se utilizan para promover pautas de tratamiento nacionales establecidas. Además, los protocolos de terapia escalonada contribuyen a la promoción de terapias con medicamentos seguros y accesibles.

Some drugs are restricted to a particular gender and/or age group for coverage. This is based on how the drug is to be used and the subpopulation the drug is intended to treat.

If you have questions about a step therapy regimen, call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m. - 9 p.m. EST.

Excepción y rechazo de solicitudes
For an exception to a Medicare Part D drug management tool, providers should call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m.-9 p.m. EST.

For information about Exception and Appeals take the following steps:

  • Go to the "Provider" area of www.humana.com
  • Under "Quick Links," choose "Prescription Tools"
  • Scroll down to the "Exception and Appeals" link

Generally, HCPR will give providers a decision within 72 hours of receiving their supporting statement for authorization. Providers can request an expedited review if the standard response time would cause serious harm or endanger a member's health. HCPR will make the decision within 24 hours if the patient's medical condition requires it.

Volver arriba

Web-based authorizations now available!

Providers now have a faster way to request drug prior authorizations (PAs) – via the Web. The Web PA tool aims to help providers save time and eliminate confusion for physicians and their patients. The advantages of this service include the following:

  • Immediate response from Humana on drug PA requests
  • Aprobación al instante
  • Ability to fill prescriptions that require a PA more quickly

This market-leading innovation is available 24 hours a day in Humana's secured Provider Resource Center. To get to the tool, follow these instructions:

  • Log in to Humana's Provider Resource Center
  • Click the "Drug Prior Authorization Requests" link under the "Referrals/Authorizations" section
  • Follow the instructions and submit the request

Some drugs available for Web PA as of April 2007 include the following:

  • Byetta, Januvia, Janumet
  • Lamisil
  • Norvasc and other blood pressure drugs
  • Nexium, Prilosec, Omeprazole, Protonix, Aciphex, Prevacid and Zegerid
  • Celebrex, Mobic and Meloxicam

 

Volver arriba

Humana wants physicians to know that the following brand name drugs are now available generically:

  • Zocor
  • Zoloft
  • Pravachol
  • Ditropan XL
  • Mobic
  • Norvasc
  • Proscar
  • Prilosec
  • Flonase
  • Allegra
  • Claritin

 

Volver arriba

CMS definition of a Part D Drug

A prescription drug is a Part D drug only if it is prescribed for a medically accepted indication as defined by Medicare statute. This definition includes uses which are approved by the FDA or supported by a citation included, or approved for inclusion, in one of the following compendia:

  • American Hospital Formulary Service Drug Information
  • United States Pharmacopeia-Drug Information
  • DRUGDEX Information System

Based on this statutory definition, indications that are supported in peer-reviewed medical literature that have not yet been approved by the FDA or reflected in one of the compendia are not medically accepted. Therefore, the use of a drug for such indications would not meet the definition of a Part D drug and is not payable under the Medicare Part D benefit.

Volver arriba



Carta de Bruce Perkins
Políticas de cobertura médica para febrero, marzo y abril
Presentaciones que intentan facilitarle el trabajo
Los Webinars proporcionan un aprendizaje interactivo
Recordatorios importantes: Políticas y procesos de Humana
Humana se compromete a mejorar la calidad
La codificación apropiada de los exámenes retinales
   es necesaria para obtener datos precisos
Humana reconoce a los participantes de los Módulos
   de mejoramiento de la práctica médica
Actualizaciones en la gestión de farmacias
Apoyo para dejar de fumar para los afiliados de Medicare
Se facilita la determinación de elegibilidad para vacunas
Actualización del identificador nacional de proveedores (NPI)
Nuevas regulaciones en los derechos de apelación de altas hospitalarias
El asesoramiento telefónico de salud cosecha beneficios
Pautas para la codificación apropiada de la diabetes
Pregunte a los expertos